Roles of cardiovascular risk factors in endothelial nitric oxide synthase regulation: an update

Md Saha Jamaluddin, Zhengdong Liang, Jian-Ming Lu

  • 1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Mail Stop: BCM391, Houston, Texas 77030, USA. jchen@bcm.tmc.edu.

Insights

Cardiovascular risk factors impair the endothelial nitric oxide synthase-nitric oxide (eNOS-NO) system. Understanding these mechanisms is key to developing new strategies for preventing and treating cardiovascular disease.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Vascular Biology

Background:

  • Cardiovascular disease is a leading cause of death globally.
  • Research focuses on understanding cardiovascular risk factors and their impact on the vascular system.
  • The endothelial nitric oxide synthase-nitric oxide (eNOS-NO) system plays a crucial role in vascular health.

Purpose of the Study:

  • To review current research on how cardiovascular risk factors affect the eNOS-NO system.
  • To highlight discoveries related to both established and emerging risk factors.
  • To explore the molecular mechanisms underlying eNOS-NO system impairment.

Main Methods:

  • Literature review of recent studies on cardiovascular risk factors and the eNOS-NO system.
  • Analysis of molecular mechanisms by which risk factors impact eNOS expression, activity, and NO bioavailability.
  • Focus on established risks (hypertension, smoking, dyslipidemia, diabetes) and emerging risks (HIV, antiretroviral therapy, genetics, cytokines).

Main Results:

  • Cardiovascular risk factors commonly impair the eNOS-NO system.
  • Mechanisms include reduced NO bioavailability due to reactive oxygen species, inhibited eNOS expression/activity, and cofactor deficiency.
  • Emerging risk factors like HIV infection and antiretroviral therapy also impact the eNOS-NO system.

Conclusions:

  • Cardiovascular risk factors disrupt the eNOS-NO system through various molecular pathways.
  • Understanding these disruptions is vital for developing novel prevention and treatment strategies.
  • Further research into emerging risk factors' effects on the eNOS-NO system is warranted.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.3K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
5.5K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.9K